Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Itron’s Intelligent Connectivity Suite Now Incorporates the FirstNet Embedded IoT Program
-
American Coastal Insurance Corporation Reports Financial Results for Its Third Quarter Ended September 30, 2024
-
LiveRamp Announces Results for Second Quarter FY25
-
OrthoPediatrics Corp. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Revenue Guidance
-
Interparfums, Inc. Reports Record 2024 Third Quarter Results
-
BBSI Reports Strong Third Quarter 2024 Financial Results
-
Full House Resorts Announces Third Quarter Results
-
Crane NXT, Co. Reports Third Quarter 2024 Results
-
OraSure Reports Q3 ’24 Revenue of $39.9 Million
-
Encore Capital Group Announces Third Quarter 2024 Financial Results
-
Latham Group, Inc. to Participate in the Baird 2024 Global Industrial Conference
-
TILT Sets Third Quarter 2024 Conference Call for November 14 at 5:00 p.m. ET
-
Rapid7 Announces Third Quarter 2024 Financial Results
-
Alector Reports Third Quarter 2024 Financial Results and Provides Business Update
-
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
-
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results
-
Lesaka Q1 2025 Results: Lesaka Continues Building Operational Momentum Achieving Revenue and Profitability Guidance
-
A-Mark Precious Metals Reports Fiscal First Quarter 2025 Results
-
Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences
-
Amplify Energy Announces Third Quarter 2024 Results, Beta Drilling Results and Issuance of Sustainability Report
-
red violet Announces Third Quarter 2024 Financial Results
-
Option Care Health to Participate in Upcoming Investor Conferences
-
Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference
-
Veeco Announces Over $50 Million in Wet Processing System Orders Supporting Advanced Packaging for AI
-
Prelude Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Haoxi Health Technology Limited Receives Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
-
Seer Reports Third Quarter 2024 Financial Results
-
Veeco Reports Third Quarter 2024 Financial Results
-
MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 Guidance
-
Nyxoah Reports Third Quarter Financial and Operating Results
-
Allbirds Announces Distribution Agreements for Europe and Latin America
-
SLR Investment Corp. Announces Quarter Ended September 30, 2024 Financial Results
-
INNOVATE Corp. Announces Third Quarter 2024 Results
-
Upwork Reports Third Quarter 2024 Financial Results
-
Health Catalyst Reports Third Quarter 2024 Results
-
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
-
Revolution Medicines Reports Third Quarter 2024 Financial Results and Update on Corporate Progress
-
TerrAscend Enters Ohio with the Signing of Definitive Agreement to Acquire a Well Situated and Profitable Dispensary
-
Outset Medical Reports Third Quarter 2024 Financial Results
-
Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results
-
Celldex Reports Third Quarter 2024 Financial Results and Provides Corporate Update
-
Duolingo Achieves 54% DAU growth and 40% Revenue Growth in Third Quarter 2024
-
LegalZoom Reports Third Quarter 2024 Financial Results
-
scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
-
Asure Software Sets November and December 2024 Investor Conference Schedule
-
Cardlytics Announces Third Quarter 2024 Financial Results
-
NMI Holdings, Inc. Reports Third Quarter 2024 Financial Results; Announces New Reinsurance Agreements
-
Coherus BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update
-
Genelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation Conference
-
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results


